322 results
Page 5 of 17
8-K
EX-99.1
105h2ty vtfgmdap
17 Jul 19
Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005
9:07am
8-K
EX-99.1
38s252r7n4n3izrh
27 Jun 19
Validated, Pre-Clinical Success Shown in Modifying the Regulation of the SNCA Gene Which Encodes Alpha-Synuclein Expression
7:24am
8-K
EX-1.1
gspwwbol4ltm e403j
17 Jun 19
Entry into a Material Definitive Agreement
9:55pm
8-K
EX-10.2
o16uxshwd43dkupjo
26 Mar 19
Departure of Directors or Certain Officers
4:55pm
8-K
EX-10.1
vcl8n9 5trdg371
8 Mar 19
Entry into a Material Definitive Agreement
6:39am
8-K
EX-99.1
j665rzd0kyw7wvo
19 Feb 19
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
8:00am
8-K
EX-2.1
kw9bb7
19 Feb 19
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
8:00am
424B3
0c7q1
13 Feb 19
Prospectus supplement
4:45pm
424B3
om57fjacc25qa0
13 Feb 19
Prospectus supplement
4:44pm
8-K
EX-4.1
ilde0n 4y85hoo6
6 Feb 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-4.2
dryek5h6jq x6iptd7f
6 Feb 19
Entry into a Material Definitive Agreement
4:15pm
8-K
4fnr1p
24 Jan 19
Completion of Acquisition or Disposition of Assets
8:05am
8-K
EX-99.1
75it2f9q5bez1nzz8uq8
24 Jan 19
Completion of Acquisition or Disposition of Assets
8:05am
425
EX-10.1
hk3m 47npjud
16 Jan 19
Business combination disclosure
12:00am